membrane vesicles (DMVs), but the role of DMVs in replication and virus fitness remains 23 unclear. Coronaviruses encode 16 nonstructural proteins (nsps), three of which -nsp3, nsp4, 24 and nsp6 -are necessary and sufficient for DMV formation. It has been shown previously that 25 mutations in murine hepatitis virus (MHV) nsp4 loop 1 that alter nsp4 glycosylation are 26 associated with disrupted DMV formation and result in changes in virus replication and RNA 27 synthesis. However, it is not known whether DMV morphology or another function of nsp4 28 glycosylation is responsible for effects on virus replication. In this study we tested whether 29 mutations across nsp4, both alone and in combination with mutations that abolish nsp4 washed twice with PBS, media was replaced, and cells were incubated at 37°C. Supernatants 150 were sampled from 30 min to 24 h post infection (p.i.) and viral titers were determined by plaque 151 assay, as previously described (24) . 152
Radiolabel of viral proteins and protein immunoprecipitation. DBT cells were 153
infected at an MOI of 10 PFU/cell or mock infected. At 4 h p.i., the medium was replaced with 154 DMEM that lacks cysteine and methionine and supplemented with 20 μg/ml actinomycin D 155 (ActD; Sigma Lysates and immunoprecipitated as previously described (1). 159
Immunofluorescence Assay. DBT cells on glass coverslips were mock-infected or 160 infected with WT or nsp4 mutant viruses. At 7 h p.i., medium was aspirated and cells were fixed 161 in 100% methanol at -20°C. Cells were then rehydrated in PBS for 10 min and blocked in PBS 162 containing 5% bovine serum albumin. For indirect immunofluorescence, cell were incubated 163 with nsp4 in wash solution (1% bovine serum albumin and 0.05% NP40 in PBS) containing 2% 164 normal goat serum for 45 min. Cells were then washed 3 times for 5 min each in wash solution. 165
Cells were then incubated with goat anti-rabbit Alexa 488 at 1:1000 for 30 min at room 166 temperature. Anti-nsp8 directly conjugated to Alexa-546 was used for direct 167 immunofluorescence, as previously described (1). Cells were incubated with anti-nsp8 at 1:200 168 dilution for 30 min at room temperature. Cells were then washed three times in wash solution for 169 5 min each before a final wash in PBS for 30 min. PBS was then aspirated and replaced with 170 distilled water. Coverslips were mounted to glass slides using aquapolymount (Polysciences) and 171 visualized using a Ziess LSM 510 META Inverted confocal microscope with a 40X oil 172 immersion lens. Images were merged and processed using Adobe Photoshop CS5. 173 on July 13, 2017 by guest http://jvi.asm.org/ Downloaded from qRT-PCR. Total intracellular RNA was extracted in TRIzol (Invitrogen) using the 174 manufacturers protocol. Viral RNA (1 μg) was then reverse transcribed using Superscript III 175 (Invitrogen) and random hexamers (Roche). qRT-PCR was performed as previously described 176 (25). Briefly, qPCR was performed on the RT product using the Applied Biosciences 7500 Real-177
Time PCR System with Power SYBR Green PCR Master Mix (Life Technologies). Values were 178 normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The Kruskal-Wallis test 179 was used to determine statistical differences between WT and mutant levels of RNA synthesis. 180
Transmission Electron Microscopy. DBT cells were mock infected or infected with 181
WT or nsp4 glycosylation mutant viruses at an MOI of 5 PFU/cell in 3 60-mm dishes per sample 182 and incubated at 37°C. At 8 h p.i., medium was aspirated, and cells were washed once with PBS. 183
The cells were then fixed in 2% glutaraldehyde for 10 minutes, scraped off the dishes, and 184 pelleted. The initial 2% glutaraldehyde was aspirated, fresh 2% glutaraldehyde was added to the 185 fixed cells for 1 h, aspirated, and fresh glutaraldehyde was added to the fixed cells for overnight 186 incubation at 4°C. Cells were washed three times in PBS, transferred to 1% osmium tetroxide in 187 
Mutations across nsp4 impair DMV morphology and numbers. In order to test 217
whether nsp4 glycosylation regulates proper DMV formation independent of its position in the 218 protein, we engineered mutations to introduce a glycosylation sequon, Nx(S/T) at different 219 locations in the nsp4-DGM (double glycosylation mutant (N176A/N237A)) background (Fig 1) . 220
Two viruses were engineered to insert predicted glycosylation sites from other coronaviruses; 221 V129N/Q130I is the glycosylation sequon of SARS-CoV, and N479S introduced the sequon 222 present in both HCoV-OC43 and Bovine CoV (BoCV). All other mutations were inserted near 223 highly conserved asparagine, serine or threonine residues to introduce new potential Nx(S/T) 224 sequons ( Fig. 1 ). Both strategies have successfully been used to introduce glycosylation sites into 225 proteins (27-30). We recovered three mutants in the DGM background and one in the WT 226 background; viruses that contain Nx(S/T) mutations from other coronaviruses (DGM-227 V129N/Q130I and DGM-N479S), as well as one that was introduced after a conserved 228 asparagine (DGM-K85S). Additionally, N479S was recovered in the WT-nsp4 background. Table 2 ). Cells infected with DGM-N479S and N479S produced fewer aberrant 251 DMVs (54% and 53% respectively) than DGM, but more aberrant DMVs than WT (37%). Next, 252 the number of DMVs per area cytoplasm was calculated to determine whether the differences in 253 total number of DMVs counted per sample correspond to differences in total numbers of DMVs 254 (Fig. 2) . DGM, DGM-K85S and N479S had significantly decreased number of DMVs compared 255 to WT (Fig. 2I ). The differences in total numbers of DMVs may be due to direct effects of 256 mutations in nsp4 or may reflect differences in the degree of viral replication occurring. These 257 data demonstrate that inserting additional mutations within loop 1 of nsp4 exacerbates the 258 aberrant DMV formation associated with the DGM phenotype. Additionally, these data 259 demonstrate that mutations within the C-terminus of nsp4 cause aberrant DMVs independent of 260 mutations within loop 1. 261
Nsp4 Nx(S/T) sequons do not complement defects in replication or nsp4 262
glycosylation. Next we sought to determine whether the viruses with aberrant DMVs were 263 associated with altered replication kinetics. DBT cells were mock-infected or infected with 264 indicated viruses at an MOI of 1 PFU/cell. At indicated times, supernatants were sampled and 265 on July 13, 2017 by guest http://jvi.asm.org/ Downloaded from titered by plaque assay (Fig. 3) . WT virus began exponential replication between 4-6 h p.i. and 266 achieved peak titer at 10 h p.i. The DGM virus replicated with delayed kinetics, began 267 exponential replication between 6-8 h p.i. and achieved WT-like peak titer at 12 h p.i. N479S 268 replicated indistinguishably from WT, and the DGM-K85S and DGM-N479S viruses replicated 269 indistinguishably from the parental DGM virus. The DGM-V129N/Q130I mutant displayed 270 delayed exponential replication and peak titer compared with both WT and the parental DGM 271
virus. 272
These data suggested that either glycosylation at alternate residues did not complement 273 the replication delay of DGM, or that these nsp4 proteins were not glycosylated. To determine 274 the glycosylation status of the mutant nsp4 proteins, virus-infected cells were radiolabeled, and 275 cell lysates were immunoprecipitated with antibodies specific for nsp4 followed by treatment 276 with EndoH to remove N-linked glycans (Fig. 3) . WT nsp4 migrated at 44kDa in the absence of 277
EndoH, and displayed a mobility shift to 39kDa following EndoH treatment, indicative of the 278 removal of two glycans, each with an expected mobility shift of 2.5kDa. The N176A virus is 279 glycosylated at one site (42kDa) and DGM lacks glycosylation and migrated at 39kDa. In 280 contrast, all of the alternate Nx(S/T) mutant viruses in the DGM background migrated at 39kDa 281 regardless of EndoH treatment, indicating that the mutant nsp4 proteins were not glycosylated. 282
The N479S nsp4 protein migrated at 44kDa in absence of EndoH and shifted to 39kDa in the 283 presence of EndoH, demonstrating that this nsp4 protein is glycosylated at the native 284 glycosylation sites only. While we can draw no conclusions from inability to recover virus 285 mutants, we did observe that all recovered viruses did not confer glycosylation at the introduced 286 sequon, whereas compared with a large number of mutations that are tolerated in nsp4, several 287 attempted new Nx(S/T) sequons in loop 1 could not be recovered after multiple attempts. The 288 results led us to consider the possibility that sequons capable of glycosylation may not be 289 tolerated in loop 1. 290
Nsp4 Nx(S/T) mutants have WT-like RNA synthesis. Since the differences in total 291
DMV numbers demonstrated by EM may reflect overall differences in viral replication, next we 292 assessed the RNA synthesis capacity of these viruses. DBT cells were infected at an MOI of 1 293 PFU/cell for 10 h. Total cellular RNA was harvested in TRIzol and qRT-PCR performed to 294 amplify nsp10 and GAPDH. All viruses have RNA synthesis levels indistinguishable form WT 295 (Fig. 4) . It is likely that similar to replication kinetics, if time points were taken, there would 296 
synthesis. 299
Nsp4 Nx(S/T) mutants localize to the replication complex. In order to determine 300 whether differences in total numbers of DMVs corresponds to differences in replication complex 301 formation and overall protein levels, DBT cells on coverslips were infected with WT or the nsp4 302
Nx(S/T) viruses at an MOI of 5 PFU/cell for 6.5 h (Fig 5) . Cells were then fixed in methanol 303
and stained with antibodies specific to nsp4 and nsp8, a marker for the replication complex. In 304
WT-infected cells, nsp4 and nsp8 colocalize at punctate perinuclear foci. All mutant nsp4 protein 305 extensively colocalize with nsp8 at perinuclear foci. This data demonstrates that the Nx(S/T) 306 mutant nsp4 proteins localize to the replication complex. Additionally, there is no apparent 307 correlation between aberrant DMV formation and the level of replication complex formation or 308 protein expression. Collectively, the RNA synthesis and immunofluorescence data indicate that 309 the difference in total numbers of DMVs does not reflect overall replication or protein expression 310 within these infected cells. 311
Substitutions in nsp4 loop1 alter replication kinetics and DMV morphology 312
independent from glycosylation status. Having demonstrated that mutations in nsp4 loop 1 313 exacerbate aberrant DMV morphology associated with the DGM phenotype, we tested whether 314 any mutation in nsp4 loop 1, independent of glycosylation potential, impacted replication and 315 DMV morphology/numbers. Nsp4 loop 1 mutants previously reported from our lab were tested 316 (Fig. 6 ): K44A/D47A (VUJS11), E226A/E227A (VUJS17), and N258T (5, 21). In contrast to 317 WT MHV-A59, all three mutant viruses exhibited a range of replication defects. The N258T 318 mutant was minimally delayed but achieved WT-like titers; the K44A/D47A mutant was more 319 delayed in both exponential replication and peak titer; and the E226A/E227A mutant showed a 320 significant delay but achieved WT like peak titer (Fig. 6C) . We then tested for the glycosylation 321 status of the mutant nsp4 proteins by radiolabel and immunoprecipitation. All nsp4 loop 1 322 mutant nsp4 proteins migrated at 44kDa in absence of EndoH and at 39kDa in the presence of 323
EndoH. These results show that all tested nsp4 loop 1 mutants are glycosylated at both native 324 asparagine residues. Thus the observed replication defects were not due to changes in 325 glycosylation status of the protein. Finally, we examined the DMV morphology and numbers in 326 mutant virus infected cells (Fig. 7 and Table 2 ). Similar to the N479S mutation alone, each of the 327 Loss of nsp4 glycosylation results in decreased virus fitness. We next tested the effect 335 of nsp4 mutations on virus competitive fitness. In order to test the fitness of nsp4 mutant viruses 336 compared to WT or DGM, DBT cells were co-infected at a ratio of 1:1, and passage three times 337 at 37°C (Fig. 8A) . The N258T and N479S viruses competed equally with WT and were 338 maintained about 50 percent of the population. In contrast, viruses lacking glycosylation of nsp4 339 exhibited profoundly decreased fitness compared to WT. We next competed DGM-K85S and 340
DGM-N479S with DGM, to test the effects of additional mutations within the DGM virus on 341
fitness (Fig. 8B) . When K85S was introduced into DGM-nsp4 loop 1 (DGM-K85S), virus fitness 342 was further deceased relative to DGM. However, DGM-N479S competed equally with DGM and 343 each remained approximately 50 percent of the population. The results suggest that the decrease 344 in fitness of DGM-N479S compared to WT is likely due to the DGM phenotype and that the 345 N479S mutation does not alter virus fitness. Collectively these data demonstrate that loss of nsp4 346 glycosylation is associated with a substantial decrease in virus fitness that can then be further 347 decreased by introduction of additional mutations into DGM-nsp4 loop 1. 348
349

Discussion 350
The role of host cytoplasmic membrane modifications in coronavirus replication and 351 fitness is a subject of increasing investigation and interest for understanding replication, 352 pathogenesis, and possible pathways for broad-spectrum inhibition of coronavirus infection. Intact nsp4 is required for proper DMV morphology. We previously reported that 362 mutations in nsp4 loop 1 were important for efficient RNA synthesis (5). We also described 363 glycosylation of nsp4 at N-linked glycosylation sites in loop one and the negative effect on DMV 364 formation by elimination of these sites (1). Our current results indicate multiple residues and 365 domains within nsp4, even in the C-terminal non-TM domain, impact DMV morphology, rather 366 than glycosylation alone. In addition, mutations in other regions of nsp4 loop 1 exacerbated 367 changes in membrane structures of the DGM virus. Angelini et al. demonstrated that when co-368 expressed, nsp3 and nsp4 have the capacity to pair membranes (3). Likely, nsp3 and nsp4 369 interact across the DMV lipid bilayer to hold both membranes in close proximity. In this model, 370
any perturbation of the nsp3-nsp4 interaction could result in separations of the inner and outer 371 membranes. Our present results in fact support that it is possible to dysregulate nsp4 functions in 372 DMV formation by mutations at several locations in nsp4 loop 1, as well as, other locations 373 including the C-terminal 10 kDa region, not predicted to be luminal or transmembrane. Since 374 the mutation in the C-terminus induced aberrant DMV formation, this would suggest that the 375 nsp4 C-terminus also is involved in DMV formation or stability after formation. We previously 376 have demonstrated the nsp4 C-terminal 10 kDa portion of the protein is dispensable for viral 377 replication in culture (5). The crystal structure of the C-terminus of nsp4 for MHV A59 and 378
Feline CoV have been determined and are structurally conserved (32, 33). The N479S residue 379 maps to a surface exposed loop in the MHV A59 C-terminus crystal structure. The DMV 380 morphology phenotype was the same between N479S and DGM-N479S, even though the viruses 381 exhibit differences in replication kinetics (Fig. 2 and 3 ). This suggests that even mutations that 382 do not effect viral replication can alter DMV morphology and numbers. Our data, in combination 383 with other studies suggests that DMV presence and not morphology is critical for efficient viral 384 replication (31, 34). by demonstrating that alterations in DMV morphology and total numbers are not associated with 395 a fitness cost compared to WT virus (WT versus N258T or N479S; Fig. 8 ). Previously we 396 observed that mutation of the nsp4 glycosylation sites alter DMV morphology and the current 397 study extends the result by demonstrating that loss of nsp4 glycosylation is associated with a 398 substantial fitness cost. We cannot conclude that the decreased fitness is due to changes in DMV 399 morphology or numbers because mutations across nsp4 that do not alter virus fitness cause 400 aberrant DMVs and decreased numbers regardless of location. viruses at an MOI of 1 PFU/cell for 10 h. Cells were then harvested in TRIzol and genomic RNA 558 was extracted. Genomic RNA levels were determined by qRT-PCR using primers specific to 559
Orf1a. RNA levels were normalized using 2 -ΔCt to endogenous GAPDH expression. Mean values 560 ± S.E.M. are shown, n≥3. RNA synthesis levels were not significantly different from WT using 561 the Kruskal-Wallis test. viruses at a total MOI of 0.1 PFU/cell at a 1:1 ratio. When cells were at least 50% involved in 591 cytopathic effect, supernatants were collected and cell monolayers were harvested in TRIzol. 592
Supernatants were used for subsequent passage for a total of three passages. Total RNA was 593 extracted and nsp4 amplicons were generated by RT-PCR and sequenced. For residues of interest, 594 area under the peak was calculated using MacVector 13. Then the percentage of nucleotides of 595 virus A to virus B was calculated and plotted on the graph. Error bars represent SEM, n≥2. 596 Table 1 . Primers used for alternate NXS/T mutagenesis.
Primer Name
Sequence Purpose K85S sense 5'-CCGCAACTCTTTCGCTTGTCCTG-3' Mutagenesis for K85S
